...
机译:酪氨酸激酶抑制剂和免疫检查点抑制剂在试剂突变体转移性黑色素瘤中的反应
Univ Texas MD Anderson Canc Ctr Div Canc Med Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Melanoma Med Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Biostat Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Melanoma Med Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Pathol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Translat Mol Pathol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Translat Mol Pathol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Surg Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Pathol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Melanoma Med Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Invest Canc Therapeut Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Syst Biol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Hematopathol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Biostat Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Melanoma Med Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Pathol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Melanoma Med Oncol Houston TX 77030 USA;
机译:酪氨酸激酶抑制剂和免疫检查点抑制剂在试剂突变体转移性黑色素瘤中的反应
机译:转移肾细胞癌中酪氨酸激酶抑制剂和免疫检查点抑制剂的联合治疗结果 - 回顾性研究
机译:通过免疫检查点抑制剂和激酶抑制剂的连续治疗中的细胞因子释放综合征,转移黑色素瘤
机译:使用酪氨酸激酶抑制剂和衡量化疗,从而改善狗的抗肿瘤
机译:了解肾上腺素能应激信号如何影响抗肿瘤免疫应答以及检查点抑制剂在鼠肿瘤模型中的疗效
机译:Lenvatinib在免疫检查点抑制剂和血管内皮生长因子受体 - 酪氨酸激酶抑制剂治疗后Lenvatinib患者或没有血管血管患者的转移性肾细胞癌
机译:Lenvatinib在免疫检查点抑制剂和血管内皮生长因子受体 - 酪氨酸激酶抑制剂治疗后,Lenvatinib患者或没有血管血管患者的转移性肾细胞癌